Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.20.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenue $ 46,279 $ 29,101
Operating expenses    
Research and development 54,996 41,490
General and administrative 18,440 18,442
Total operating expenses 73,436 59,932
Loss from operations (27,157) (30,831)
Interest income 1,714 1,962
Other (expense) income, net (26) 1,803
Loss before income taxes (25,469) (27,066)
Benefit for income tax 0 (312)
Net loss (25,469) (26,754)
Other comprehensive income/(loss) components:    
Foreign currency translation 973 1,196
Unrealized gain on available-for-sale securities, net of taxes of $0 and $164, respectively 14 517
Comprehensive loss (24,482) (25,041)
Reconciliation of Net Loss to net Loss Attributable to Common Stockholders [Abstract]    
Net loss attributable to common stockholders $ (28,299) $ (26,754)
Net loss per share:    
Basic and diluted (USD per share) $ (0.56) $ (0.50)
Weighted average number of common shares outstanding used in net loss per share attributable to common stockholders    
Basic and diluted (shares) 50,625 53,081
Series C Convertible Preferred Stock    
Reconciliation of Net Loss to net Loss Attributable to Common Stockholders [Abstract]    
Accretion of Series C convertible preferred stock $ (2,830) $ 0